Literature DB >> 23142198

Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease.

Weiyang Tao1, Xue Xu, Xia Wang, Bohui Li, Yonghua Wang, Yan Li, Ling Yang.   

Abstract

ETHNOPHARMACOLOGY RELEVANCE: Cardiovascular and cerebrovascular diseases (CCVD), an abnormal function of the heart, brain or blood vessels, are the biggest cause of deaths worldwide. Traditional Chinese medicine (TCM) holds a great promise for preventing such diseases in an integrative and holistic way. However, its systems-level characterization of drug-target associations is still unknown.
METHODS: Here, we have constructed a computational approach by combining chemical predictors based on chemical structure, chemogenomics data linking compounds with pharmacological information, and a system biology functional data analysis and network reconstruction method.
RESULTS: The pharmacological system generated 58 bioactive ingredients from the Chinese herbal Radix Curcumae formula, and predicted 32 potential targets related to the CCVD. The results indicates that Radix Curcumae share the most common targets with Fructus Gardeniae (15), while less common targets with Moschus and Borneolum (8 and 1, respectively). Further integrated network shows that Radix Curcumae represents the principal component for the prevention of CCVD, and other three medicines serve as adjuvant ones to assist the effects of the principal component, which together probably display synergistic actions.
CONCLUSIONS: Our work successfully explains the mechanism of efficiency of Radix Curcumae formula for the prevention of CCVD, and meanwhile, predicts the potential targets of the Chinese medicines, which facilitates to elucidate the compatible mechanism of the complex prescription, i.e., "jun-chen-zuo-shi", and provides basis for an alternative approach to investigate novel TCM formula on the network pharmacology level.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142198     DOI: 10.1016/j.jep.2012.09.051

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  180 in total

1.  Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.

Authors:  Yan-qiong Zhang; Song-song Wang; Wei-liang Zhu; Yan Ma; Fang-bo Zhang; Ri-xin Liang; Hai-Yu Xu; Hong-jun Yang
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

2.  System-level multi-target drug discovery from natural products with applications to cardiovascular diseases.

Authors:  Chunli Zheng; Jinan Wang; Jianling Liu; Mengjie Pei; Chao Huang; Yonghua Wang
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

3.  San-Cao Granule () Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway.

Authors:  Shi-Zhang Wei; Sheng-Qiang Luo; Jian Wang; Jia-Bo Wang; Rui-Sheng Li; Xiao-Mei Zhang; Yan-Lei Guo; Chang Chen; Xiao Ma; Zhe Chen; Hong-Hong Liu; Zhi-Rui Yang; Jian-Yu Li; Rui-Lin Wang; Ya-Ming Zhang; Hui-Yin Yang; Xiao-He Xiao; Yan-Ling Zhao
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

4.  A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.

Authors:  Teng Wang; Chun-Yi Lyu; Yue-Hua Jiang; Xue-Yan Dong; Yan Wang; Zong-Hong Li; Jin-Xin Wang; Rui-Rong Xu
Journal:  Mol Divers       Date:  2020-07-16       Impact factor: 2.943

5.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

6.  In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds.

Authors:  Hamisi M Malebo; Sarah D'Alessandro; Yehenew A Ebstie; Harouna Sorè; Alain R Tenoh Guedoung; Shaaban J Katani; Silvia Parapini; Donatella Taramelli; Annette Habluetzel
Journal:  Drug Des Devel Ther       Date:  2020-04-28       Impact factor: 4.162

7.  Systemic pharmacological investigation of the Feng Shi Gu Tong capsule in the treatment of rheumatoid arthritis.

Authors:  Xin Wei; Wanjin Fu; Renpeng Zhou; Yong Chen; Chao Lu; Wei Hu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-01       Impact factor: 3.000

8.  Prediction of Targets of Curculigoside A in Osteoporosis and Rheumatoid Arthritis Using Network Pharmacology and Experimental Verification.

Authors:  Jiawen Han; Minjie Wan; Zhanchuan Ma; Cong Hu; Huanfa Yi
Journal:  Drug Des Devel Ther       Date:  2020-11-26       Impact factor: 4.162

9.  Identification of phytochemicals from North African plants for treating Alzheimer's diseases and of their molecular targets by in silico network pharmacology approach.

Authors:  Karim Raafat
Journal:  J Tradit Complement Med       Date:  2020-08-12

10.  Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models.

Authors:  Tongxing Wang; Lu Liang; Chunlai Zhao; Jia Sun; Hairong Wang; Wenjia Wang; Jianping Lin; Yunhui Hu
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.